Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from HBM Holdings Ltd. ( (HK:2142) ) is now available.
HBM Holdings Ltd. announced that it has received an upfront payment from Windward Bio AG as part of an exclusive license agreement for HBM9378/SKB378. This payment, which includes both cash and equity interest, is expected to strengthen the company’s cash reserves, potentially enhancing its operational capabilities and market positioning.
More about HBM Holdings Ltd.
HBM Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. Its primary focus is on the development and commercialization of innovative therapeutics, with a market focus on advancing biopharmaceutical solutions.
YTD Price Performance: 194.09%
Average Trading Volume: 6,962,549
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$4.13B
For detailed information about 2142 stock, go to TipRanks’ Stock Analysis page.